Jamie Yieh releases debut novel Leaf
Jamie Yieh has published his debut novel, Leaf, a speculative fiction thriller centered on family legacy, cultural identity and medical innovation. The book is now available through major retailers as Yieh also works on a second novel.
Why it matters: - Jamie Yieh’s debut novel combines speculative fiction with Asian American family drama and medical-thriller elements. - The book aims at readers interested in multigenerational stories, identity, and the ethical weight of scientific innovation. - The release adds a new literary voice from a Chinese American author with a biomedical engineering background.
What happened: - Jamie Yieh, a Chinese American author and biomedical engineer, released his debut novel, Leaf. - The novel is a speculative fiction thriller set around family legacy, cultural identity, sacrifice, and medical innovation. - The book is available worldwide through retailers including Amazon and Barnes & Noble. - The paperback price is $18.99, and the ebook price is $3.99. - The ISBN is 9781970844443.
The details: - Leaf follows multiple protagonists across intersecting timelines. - The story centers on first-generation Chinese Americans navigating the impact of past choices. - One thread follows David Shia, an aspiring entrepreneur chasing love and trying to escape his family’s history. - Another follows Michael Shie, a rising NBA player who crosses paths with David’s former love interest on a movie set. - A third follows James Xie, a health sciences innovator who has engineered nanotechnology designed to heal brain illnesses. - The novel uses the shifting perspectives to connect personal history with scientific advance. - Yieh said he wanted readers to feel the link between past and present and how roots shape people even when they do not notice it. - Yieh holds a Bachelor of Science in Biomedical Engineering from Boston University and an MBA from Rutgers University. - Yieh has 25 years of experience in the medical device industry. - Yieh said the story draws from his experience balancing tradition and ambition. - Yieh is also working on a second novel, C^2, a sci-fi thriller about a med-tech experiment gone awry. - Review copies and interviews are available upon request. - Readers can purchase the book on Amazon through the retailer listing referenced in the release.
Between the lines: - Leaf appears positioned as both entertainment and commentary on inheritance, belonging and the pressure of family expectations. - Yieh’s biomedical engineering background gives the medical innovation in the novel a technical angle that may set it apart from standard genre fiction. - The release leans on cross-genre appeal, which can broaden the book’s audience beyond traditional literary fiction readers.
What's next: - Yieh’s next project, C^2, extends his focus on speculative med-tech storytelling. - Manhattan Book Group is promoting Leaf to readers seeking genre-blending fiction and author media opportunities. - The book’s availability through major retailers suggests an immediate push for broad consumer reach.
The bottom line: - Leaf is a debut novel built around family history, identity and science, with a clear commercial launch and a second book already in progress.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Everything Worth Reading
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.